Alpha Tau Medical
- Country
- 🇮🇱Israel
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 121
- Market Cap
- -
- Website
- http://www.alphatau.com
- Introduction
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors
- Conditions
- Cutaneous TumorSkin CancerCutaneous Metastasis
- Interventions
- Device: DaRT- Diffusing Alpha-emitters Radiation Therapy
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 80
- Registration Number
- NCT04068155
- Locations
- 🇫🇷
CHU Grenoble Alpes, Grenoble, France
🇫🇷Centre Léon Bérard, Lyon, France
Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer
- Conditions
- Pancreatic AdenocarcinomaUnresectable Pancreatic CancerMetastatic Pancreatic CancerPancreatic Cancer
- First Posted Date
- 2019-06-28
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 37
- Registration Number
- NCT04002479
- Locations
- 🇨🇦
Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada
🇨🇦Jewish General Hospital, Montréal, Quebec, Canada
Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases
- Conditions
- Breast CarcinomaMetastatic Breast CancerDistant Metastases.PathologyInvasive Breast Cancer
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 1
- Registration Number
- NCT03970967
- Locations
- 🇷🇺
A. Tsyb Medical Radiological Research Center, Obninsk, Kaluga Region, Russian Federation
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
- Conditions
- Soft Tissue NeoplasmSkin CancerMucosal Neoplasm of Oral Cavity
- First Posted Date
- 2019-03-26
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 30
- Registration Number
- NCT03889899
- Locations
- 🇮🇱
RAMBAM Health Care Campus, Haifa, Israel
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
- Conditions
- Soft Tissue NeoplasmSkin CancerMucosal Neoplasm of Oral Cavity
- First Posted Date
- 2019-03-22
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 35
- Registration Number
- NCT03886181
- Locations
- 🇮🇹
IRCCS Istituto Dermatologico S. Gallicano, IFO - Istituti Fisioterapici Ospitalieri - Dermatologia Oncologica e Prevenzione, Rome, Lazio, Italy
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
- Conditions
- Skin CancerSoft Tissue NeoplasmMucosal Neoplasm of Oral Cavity
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 30
- Registration Number
- NCT03737734
- Locations
- 🇮🇱
Davidof Cancer Institution at the Rabin Medical Center Israel, Petah tikva, Israel
Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)
- Conditions
- Skin Squamous Cell Carcinoma
- First Posted Date
- 2017-11-27
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 28
- Registration Number
- NCT03353077
- Locations
- 🇮🇹
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, Italy
Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma
- Conditions
- Squamous Cell Carcinoma
- Interventions
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
- First Posted Date
- 2017-01-10
- Last Posted Date
- 2021-01-13
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 28
- Registration Number
- NCT03015883
- Locations
- 🇮🇱
Davidof Cancer Institution at the Rabin Medical Center Israel, Petah Tiqva, Israel